Enrofloxacin monohydrochloride
CAS : 93106-59-3
Ref. 3D-TDA10659
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 25g | Arrêté | ||
| 50g | Arrêté | ||
| 250mg | Arrêté | ||
| 2500mg | Arrêté |
Informations sur le produit
Nom :
Enrofloxacin monohydrochloride
Synonymes :
- 3-Quinolinecarboxylicacid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-,monohydrochloride (9CI)
Description :
Enrofloxacin monohydrochloride is a medicinal product that acts as a protein kinase inhibitor. It has been shown to inhibit the growth of cancer cells, including leukemia cells, by inducing apoptosis and cell cycle arrest. Enrofloxacin monohydrochloride has been tested in Chinese hamster ovary cells and found to be effective in inhibiting tumor growth. This drug is excreted mainly through urine and has been shown to have anticancer properties due to its ability to inhibit protein kinases involved in cancer cell proliferation. Enrofloxacin monohydrochloride is a promising therapeutic option for the treatment of various types of cancer in humans.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
395.9 g/mol
Formule :
C19H23ClFN3O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
